Clinicopathological parameters | Number | MTSS1/GAPDH mRNA (n) | P | |
---|---|---|---|---|
MTSS1-low group | MTSS1-high group | |||
(≤0.18, n = 17) | (>0.18, n = 20) | |||
Age | 37 | Â | Â | 0.900 |
  ≤ 52 y | 20 | 9 | 11 |  |
  > 52 y | 17 | 8 | 9 |  |
Sex | 37 | Â | Â | 0.588 |
 Female | 8 | 3 | 5 |  |
 Male | 29 | 14 | 15 |  |
Cirrhosis | 37 | Â | Â | 0.855 |
 Yes | 30 | 14 | 16 |  |
 No | 7 | 3 | 4 |  |
Tumor number | 37 | Â | Â | 0.035* |
 Multiple | 20 | 6 | 14 |  |
 Single | 17 | 11 | 6 |  |
Satellite | 36a | Â | Â | 0.019* |
 Yes | 15 | 3 | 12 |  |
 No | 21 | 13 | 8 |  |
Tumor size, cm | 37 | Â | Â | 0.212 |
  ≤ 5 | 7 | 5 | 2 |  |
  > 5 | 30 | 12 | 18 |  |
Encapsulation | 37 | Â | Â | 0.008** |
 Complete | 15 | 11 | 4 |  |
 Incomplete or none | 22 | 6 | 16 |  |
Vascular invasion | 36a | Â | Â | 0.042* |
 Yes | 21 | 6 | 15 |  |
 No | 15 | 11 | 4 |  |
TNM stage | 37 | Â | Â | 0.033* |
 Early stage (II) | 7 | 6 | 1 |  |
 Advanced stage (III-IVA) | 30 | 11 | 19 |  |
AFP level, ng/mL | 37 | Â | Â | 0.036* |
  ≤ 20 | 11 | 2 | 9 |  |
  > 20 | 26 | 15 | 11 |  |
γ-Glutamyl transferase, units/L | 37 |  |  | 0.134 |
  ≤ 54 | 19 | 11 | 8 |  |
  > 54 | 18 | 6 | 12 |  |
Adjuvant TACE | 37 | Â | Â | 0.815 |
 Yes | 16 | 7 | 9 |  |
 No | 21 | 10 | 11 |  |